VCAN and breast carcinoma: Versican G3 domain enhanced breast cancer progression, metastasis, chemical reagent (i.e. chemotherapy) resistance, and tumor cell self-renewal is modulated by the up-regulation of Epidermal Growth Factor Receptor (EGFR)-mediated signaling [22-24].